The X-ray Crystallographic Structure of the Angiogenesis Inhibitor Angiostatin
Authors:
- R.K. ArniRAR.K. Arni
- Davida K. GrellaDGDavida K. Grella
- Francis J. CastellinoFCFrancis J. Castellino
- Alexander TulinskyATAlexander Tulinsky
- James H. GeigerJGJames H. Geiger
- 1 May 2002
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 318 (4) , 1009-1017
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Angiogenesis in cancer and other diseasesNature, 2000
- Inhibition of human malignant glioma growthIn vivo by human recombinant plasminogen kringles 1-3International Journal of Cancer, 1999
- Suppression of angiogenesis and tumor growth by the inhibitor K1–5 generated by plasmin-mediated proteolysisProceedings of the National Academy of Sciences, 1999
- Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolutionThe EMBO Journal, 1998
- The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatinProceedings of the National Academy of Sciences, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Kringle Domains of Human AngiostatinJournal of Biological Chemistry, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Angiogenesis.Journal of Biological Chemistry, 1992